investor login

contact

team

dedicated funds

news

 portfolio

Tune Therapeutics is a cutting-edge biotechnology company founded by world-class leaders in epigenome editing. Tune strives to develop paradigm-changing cell and gene therapies that leverage epigenetic programming for the treatment of devastating diseases. Join a highly skilled and dynamic team with expertise that spans basic discovery all the way to clinical implementation. We are passionate about the technology and its potential to help patients in need. 

VISIT WEBSITE

Active, Bio Tech, HOF I, HVP VI

back to portfolio

contact

© hatteras venture partners | all rights reserved | terms + privacy | site credit

 team

 portfolio

news

home

Hatteras Venture Partners is a venture capital firm that builds transformational companies in areas of health innovation.

dedicated funds

contact

 team

dedicated funds

news

home

 portfolio